Braavos Investment Advisers Overview

Braavos Investment Advisers is a London-based venture capital firm founded in 2019, managing over $500 million in assets. The firm focuses on early-stage investments in science and technology sectors, particularly companies leveraging scientific breakthroughs. Braavos partners with visionary entrepreneurs to transform cutting-edge research into successful businesses, emphasizing sectors such as biotechnology, artificial intelligence, renewable energy, chemical engineering, energy efficiency, and simulation. The firm has a history of leading investments in companies like OXCCU, a biotechnology firm based in Oxfordshire, United Kingdom, which received a £22 million investment in June 2023. Braavos typically invests in early-stage ventures, with an average round size of approximately £39 million. The firm's investment approach emphasizes supporting innovative companies in sectors poised for significant growth, particularly those leveraging scientific breakthroughs to address global challenges. Braavos's strategic investments aim to foster advancements in critical industries, contributing to the development of sustainable and impactful technologies. The firm's commitment to these sectors underscores its dedication to driving progress and innovation in the technology and energy landscapes.

Is Braavos Investment Advisers the right investor for your startup? Browse their investment focus, stage preferences, and geographic scope to see how well they align with your fundraising goals. Your full match score with Braavos Investment Advisers, along with a list of other relevant VCs, is available on Hopohopo.io.